Northwest Biotherapeutics reported $-95104000 in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -20385000 23.8M
AstraZeneca AZN:LN USD 35.13B 798M
Celldex Therapeutics CLDX:US USD 345.42M 19.68M
Cti Biopharma CTIC:US USD -16837000 11.56M
Cytori Therapeutics CYTX:US USD 11.4M 1.72M
Cytrx CYTR:US USD 3.28M 1.5M
Eisai 4523:JP JPY 828.13B 23.58B
Infinity Pharmaceuticals INFI:US USD -10874000 9.77M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Northwest Biotherapeutics NWBO:US USD -95104000 3.44M
Roche Holding ROG:VX 25.19B 700M